Last reviewed · How we verify
NCT04829175
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
trial testing Intervention in Stress Urinary Incontinence in 1,000 participants. Currently enrolling.
31 March 2033
Quick facts
| Lead sponsor | Ethicon, Inc. |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 11 April 2022 |
| Primary completion | 31 March 2033 |
| Estimated completion | 31 March 2038 |
| Sites | 10 locations across France, Denmark, Italy, Austria, Sweden, Germany, United States |
Drugs / interventions tested
- Intervention
Conditions studied
- Stress Urinary Incontinence — all drugs for Stress Urinary Incontinence →
- Pelvic Organ Prolapse — all drugs for Pelvic Organ Prolapse →
Sponsor
Ethicon, Inc. — full company profile →
Who can join
21 and older, female only, with Stress Urinary Incontinence or Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this post market, clinical registry is to evaluate the performance of the products of the TVT family of products or vaginal vault or uterine prolapse repair (with laparotomic or laparoscopic approach including robotic assisted) using either Gynemesh PS Mesh or Artisyn Mesh in women undergoing surgery for SUI and POP.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04829175
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intervention
Trials testing the same drug.
- NCT07038317 — A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status · NA · not yet recruiting
- NCT06112431 — Eye Health Intervention Study in Upper Manhattan · NA · not yet recruiting
- NCT07444736 — Effect of 8 Weeks of Resistance Training With Blood Flow Restriction on Muscle Strength, Clinical Parameters, Biochemica · NA · enrolling by invitation
- NCT07202390 — Intraarticular Gold Microparticles for Knee Osteoarthritis · NA · not yet recruiting
- NCT07376668 — Effects of a WhatsApp-assisted Prehabilitation for Patient Undergoing Elective Colorectal Cancer Surgery · NA · not yet recruiting
Other recruiting trials for Stress Urinary Incontinence
Currently open trials in the same condition.
- NCT06706362 — Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid (Bulkamid Study) · Phase 4 · recruiting
- NCT06924450 — Effect of Modified Mesh on Surgical Success in Transobturator Tape Surgery · NA · recruiting
- NCT06840093 — Outcomes of Limited Postoperative Restrictions Following Sling Placement: A Randomized Controlled Trial · NA · recruiting
- NCT06111209 — The Anabolic Effect of Testosterone on Pelvic Floor Muscles · Phase 2 · recruiting
- NCT06731985 — The Follow-up After Shorter Tapes Study. Effectiveness and Safety of Shorter Trans-obturator Tapes. · recruiting
Other Ethicon, Inc. trials
Trials by the same sponsor.
- NCT06664788 — A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery · NA · recruiting
- NCT05299606 — POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy) · NA · terminated
- NCT04889989 — Microwave Ablation in Chinese Patients With Lung Tumors · NA · terminated
- NCT04829058 — GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study · recruiting
- NCT04829357 — Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04829175 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ethicon, Inc.
- Last refreshed: 13 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04829175.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing